Brain Benefits: Neuroprotection and Mental Health Alzheimers and Neurodegeneration Researchers are investigating GLP-1 drugs as potential treatments for Alzheimers disease and Parkinsons disease
For example, CagriSema (cagrilintide/semaglutide), expected to file for approval in late 2025, has shown greater weight loss than Wegovy (semaglutide)
Neither is inherently better. Using 2mL of water creates a more dilute solution, which can make it physically easier to measure out precise microgram doses, as youll be drawing a larger volume into the syringe
Many are trained on retrospective datasets susceptible to hidden biases (population structure, imaging devices, healthcare access), and struggle with interpretability and calibration across diverse settings
284 Emerging epigenetic data suggest that GLP-1 RAs may decelerate biological aging via DNA methylation modifications at loci associated with inflammatory and metabolic regulation, consistent with observed reductions in biological age
Given the dual role of butyrate in regulating ferroptosis, future research should first clarify the specific molecular mechanisms by which butyrate inhibits ferroptosis in OA chondrocytessuch as through the AMPK/NRF2 pathway or downregulation of factors like LCN2and its interactions with pathological microenvironments including inflammation and ECM degradation
